Skip to Main Content

Paper Details

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.
J Vis Exp
3
2019
CD8, CD8+, DLL1, Human, Human Induced Pluripotent Stem Cells, Human iPSC, OP9, T cell, T cell lineage, T cell receptor, T cells, TCR, Tumor, Tumor Antigen-specific T Cells, advanced cancer, hiPSC, human, human tumor antigen-specific T cells, iPSC, in vitro derived T cells, lymphocytes, metastatic cancer, patients, pluripotent stem cell, rejuvenated, somatic cell, starting cell, tumor, tumor antigen-specific T cells
Author NameAffiliation
Hiroshi KawamotoInstitute for Frontier Life and Medical Sciences, Kyoto University.
Nicholas P RestifoNational Cancer Institute, NIH Center for Cell-Based Therapy
Nicholas P RestifoNational Cancer Institute, NIH Center for Cell-Based Therapy
  • 1 - 3

Datasets

Release 1.2